secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clearside Biomedical, Inc. (CLSDQ)
CIK:        0001539029
Form:       8-K
Filed at:   2024-02-01T23:59:59+00:00
Accession:  0000950170-24-009767
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Clearside reduces sublicense fees to high single digit; maintenance fees set $250K-$500K for 2023-2028
--------------------------------------------------------------------------------

- Sublicense percentage reduced from low double digits to high single digits for fees received from sublicensees.
- Maintenance fees: $250K for 2023-2025, $350K for 2026, $400K for 2027, $500K for 2028.
- 2023 maintenance fee of $250K due within 5 days of amendment execution (Jan 31, 2024).
- Reduced sublicense fee excludes R&D reimbursements, IP value transfers, and stock payments.
- Royalty rate on product sales remains unchanged at low single digit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1539029/000095017024009767/0000950170-24-009767-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1539029/000095017024009767/clsd-20240131.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-009767

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer